Skip to main content
  • Journal Highlights

    Increasing Myopia Rate in Children, the Downside of Pre-Op Testing for Cataract Surgery, and More


    Myopia Rate Increasing in Taiwanese Children

    The Downside of Pre-Op Testing for Cataract Surgery

    What Drives Noncompliance to AMD Treatment?

    Ophthalmology Glaucoma

    Endothelial Cell Loss After Baerveldt Implant Surgery

    Ophthalmology Retina

    Scleral Buckling Plus PPV for Retinal Detachment Repair

    American Journal of Ophthalmology

    Respiratory Droplets Transmitted During Slit-Lamp Exams

    Subtyping Idiopathic Uveitis by Gene Expression

    JAMA Ophthalmology

    Retinal Vascular Occlusion and Hormone Therapy in Women

    Glaucoma Macular Damage Patterns and Visual Disability

    FDA Conference Report: Ophthalmic Laser-Based Imaging

    Other Journals

    Teprotumumab for Inactive TED

    Do Structural Changes Truly Precede Functional Changes in Glaucoma?

    IRIS Registry Snapshot: Uveitis Dx and Tx

    Verana Health analyzed statistically de-identified electronic health record (EHR) data from the Academy’s IRIS Registry to assess the number of uveitis diagnoses in the United States, the location of the uveitis, and the location of steroid injections for treatment. The results include newly diagnosed cases.

    Results. All told, 662,925 eyes were diagnosed with uveitis from Jan. 1, 2016, to Nov. 6, 2020, and 193,432 eyes received a steroid injection.

    Disease location. Anterior uveitis was diagnosed in 523,120 eyes (78.9%), and posterior disease was diagnosed in 163,678 eyes (24.7%). (Percentages add up to more than 100%, as some eyes had both anterior and posterior disease.)

    Injection type. Intravitreal injections took place in 123,210 eyes (63.7%), while 86,664 eyes (44.8%) received sub-Tenon injections. (Percentages add up to more than 100%, as some eyes received injections in both locations.)

    Trend rates. During the study period, trends in rates of anterior versus posterior uveitis remained stable, as did the injection site and the number of diagnoses.

    Note: The Academy has partnered with Verana Health to curate and analyze IRIS Registry data.